106 related articles for article (PubMed ID: 21516779)
1. [Implication of integrin alpha5beta1 in human breast carcinoma apoptosis and drug resistance].
Morozevich GE; Kozlova NI; Ushakova NA; Preobrazhenskaia ME; Berman AE
Biomed Khim; 2011; 57(1):77-84. PubMed ID: 21516779
[TBL] [Abstract][Full Text] [Related]
2. Hyperexpression of Integrin α5β1 Promotes Resistance of MCF-7 Human Breast Carcinoma Cells to Doxorubicin via ERK Protein Kinase Down-regulation.
Morozevich GE; Kozlova NI; Susova OY; Lupatov AY; Berman AE
Biochemistry (Mosc); 2017 Sep; 82(9):1017-1024. PubMed ID: 28988530
[TBL] [Abstract][Full Text] [Related]
3. Integrin alpha5beta1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity.
Morozevich G; Kozlova N; Cheglakov I; Ushakova N; Berman A
Cell Cycle; 2009 Jul; 8(14):2219-25. PubMed ID: 19617714
[TBL] [Abstract][Full Text] [Related]
4. [Implication of integrin alpha5beta1 signal pathways in proliferation and apoptosis of MCF-7/Dox human breast carcinoma cells].
Kozlova NI; Morozevich GE; Ushakova NA; Gevorkian NM; Berman AE
Biomed Khim; 2016 Mar; 62(3):272-8. PubMed ID: 27420618
[TBL] [Abstract][Full Text] [Related]
5. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
6. Implication of alpha5beta1 integrin in invasion of drug-resistant MCF-7/ADR breast carcinoma cells: a role for MMP-2 collagenase.
Morozevich GE; Kozlova NI; Cheglakov IB; Ushakova NA; Preobrazhenskaya ME; Berman AE
Biochemistry (Mosc); 2008 Jul; 73(7):791-6. PubMed ID: 18707587
[TBL] [Abstract][Full Text] [Related]
7. Implication of integrins α3β1 and α5β1 in invasion and anoikis of SK-Mel-147 human melanoma cells: non-canonical functions of protein kinase Akt.
Kozlova NI; Morozevich GE; Gevorkian NM; Berman AE
Aging (Albany NY); 2020 Dec; 12(23):24345-24356. PubMed ID: 33260159
[TBL] [Abstract][Full Text] [Related]
8. Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Chewchuk S; Guo B; Parissenti AM
PLoS One; 2017; 12(2):e0172244. PubMed ID: 28196134
[TBL] [Abstract][Full Text] [Related]
9. A critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistance.
Tsou SH; Chen TM; Hsiao HT; Chen YH
PLoS One; 2015; 10(1):e0116747. PubMed ID: 25635866
[TBL] [Abstract][Full Text] [Related]
10. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
[TBL] [Abstract][Full Text] [Related]
11. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
13. T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways.
Endo Y; Shen Y; Youssef LA; Mohan N; Wu WJ
MAbs; 2018 Oct; 10(7):1003-1017. PubMed ID: 30130447
[TBL] [Abstract][Full Text] [Related]
14. The role of beta1 integrin subfamily in anchorage-dependent apoptosis of breast carcinoma cells differing in multidrug resistance.
Morozevich GE; Kozlova NI; Preobrazhenskaya ME; Ushakova NA; Eltsov IA; Shtil AA; Berman AE
Biochemistry (Mosc); 2006 May; 71(5):489-95. PubMed ID: 16732726
[TBL] [Abstract][Full Text] [Related]
15. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
16. Psammaplin A induces Sirtuin 1-dependent autophagic cell death in doxorubicin-resistant MCF-7/adr human breast cancer cells and xenografts.
Kim TH; Kim HS; Kang YJ; Yoon S; Lee J; Choi WS; Jung JH; Kim HS
Biochim Biophys Acta; 2015 Feb; 1850(2):401-10. PubMed ID: 25445714
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
18. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production.
Shi Z; Yang WM; Chen LP; Yang DH; Zhou Q; Zhu J; Chen JJ; Huang RC; Chen ZS; Huang RP
Breast Cancer Res Treat; 2012 Oct; 135(3):737-47. PubMed ID: 22923236
[TBL] [Abstract][Full Text] [Related]
19. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells.
Herman JF; Mangala LS; Mehta K
Oncogene; 2006 May; 25(21):3049-58. PubMed ID: 16449978
[TBL] [Abstract][Full Text] [Related]
20. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]